Last Updated 23 July 2021.
This vaccine is approved.
Approved in 119 countries
33 trials in 19 countries
Approval Source: health.go.ug
Non Replicating Viral Vector
This vaccine has reached Phase 1 trials.
1 trial in 1 country
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form